Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2009
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen
Chara Papadaki, Dimitris Mavroudis, Maria Trypaki, et al.
Clinical Biochemistry
|
August 19, 2006
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization
Maria Ntoulia, Loukas Kaklamanis, Christos Valavanis, et al.
Clinical Chemistry and Laboratory Medicine
|
November 24, 2004
Bone marrow microvascular density and angiogenic growth factors in multiple myeloma
Michael G Alexandrakis, Freda J Passam, Emmanuel Ganotakis, et al.
Plos One
|
September 24, 2013
Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide
Niki Karachaliou, Chara Papadaki, Eleni Lagoudaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer
Chara Papadaki, Maria Sfakianaki, Georgios Ioannidis, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 20, 2007
Her-2 protein expression, cellular localization, and gene amplification in colorectal carcinoma
Kitty Pavlakis, Panteleimon Kountourakis, Efstathios Stathopoulos, et al.
Clinical Breast Cancer
|
February 14, 2008
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer
Michail Ignatiadis, Maria Perraki, Stella Apostolaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer
Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, et al.
Plos One
|
December 25, 2013
BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome
Zacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, et al.
Plos One
|
February 2, 2011
Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients
Zacharenia Saridaki, Maria Tzardi, Chara Papadaki, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 2009
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen
Chara Papadaki, Dimitris Mavroudis, Maria Trypaki, et al.
Clinical Biochemistry
|
August 19, 2006
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization
Maria Ntoulia, Loukas Kaklamanis, Christos Valavanis, et al.
Clinical Chemistry and Laboratory Medicine
|
November 24, 2004
Bone marrow microvascular density and angiogenic growth factors in multiple myeloma
Michael G Alexandrakis, Freda J Passam, Emmanuel Ganotakis, et al.
Plos One
|
September 24, 2013
Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide
Niki Karachaliou, Chara Papadaki, Eleni Lagoudaki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer
Chara Papadaki, Maria Sfakianaki, Georgios Ioannidis, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 20, 2007
Her-2 protein expression, cellular localization, and gene amplification in colorectal carcinoma
Kitty Pavlakis, Panteleimon Kountourakis, Efstathios Stathopoulos, et al.
Clinical Breast Cancer
|
February 14, 2008
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer
Michail Ignatiadis, Maria Perraki, Stella Apostolaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer
Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, et al.
Plos One
|
December 25, 2013
BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome
Zacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, et al.
Plos One
|
February 2, 2011
Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients
Zacharenia Saridaki, Maria Tzardi, Chara Papadaki, et al.
Page
of 4